Clínica Medilaser strengthens brain tumor care in Huila

An alliance between Clínica Medilaser and the Instituto Médico Oncológico has consolidated an integrated program to treat central nervous system tumors in southern Colombia. The service, led by neurosurgeon Silvia Quintero, serves patients from several regions from its Neiva site.

The program brings together more than 14 medical specialties and holds weekly meetings to define personalized treatments. It includes psychological, social and rehabilitation support, plus high-end equipment such as specialized surgical microscopes.

Five years ago patients with skull-base tumors had to travel to Bogotá, Cali or Medellín. Now fewer than 2 % require transfer out of Neiva, according to manager Carolina Cabrera Soto.

The service treats children and adults from Huila, Caquetá, Putumayo and other areas. For minors, radiotherapy masks are customized with superhero images.

A prevention strategy will visit Paicol in June to promote early detection of symptoms such as chronic headaches.

관련 기사

Students and faculty at the new coffee university school in Huila, Colombia, surrounded by plantations.
AI에 의해 생성된 이미지

Huila creates Colombia's first university coffee school

AI에 의해 보고됨 AI에 의해 생성된 이미지

The National Ministry of Education approved six academic programs for the new Escuela Universitaria del Café in Huila, affiliated with Universidad Surcolombiana.

Medilaser Clinic’s Myriam Parra site in Neiva leads a specialized route that detects fetal diseases from pregnancy. The service serves pregnant women from southern Colombia.

AI에 의해 보고됨

The National Health Superintendency ordered the closure of plastic surgery, aesthetic and pharmaceutical services at Clínica Láser Surgical in Bogotá for violating a prior precautionary measure.

Pharmaceutical company Lilly commemorated 70 years of operations in Colombia as part of its 150-year global history.

AI에 의해 보고됨

The Ministry of Health completed its national deployment of the Oncology Alert Plan and responded to more than 30,000 patients with suspected or diagnosed cancer.

이 웹사이트는 쿠키를 사용합니다

사이트를 개선하기 위해 분석을 위한 쿠키를 사용합니다. 자세한 내용은 개인정보 보호 정책을 읽으세요.
거부